United States Patent 6,911,452
Schlienger June 28, 2005
--------------------------------------------------------------------------------
Spiroazacyclic compounds as monoamine receptor modulators
Abstract
The present invention relates to 1-oxa-3,8-diaza-spiro[4.5]decan-2-one compounds as monoamine receptor modulators; compositions comprising the same; methods of inhibiting an activity of a monoamine receptor with said compounds; methods of treating a disease condition associated with a monoamine receptor using said compounds; and methods for identifying a subject suitable for treatment using said compounds.
--------------------------------------------------------------------------------
Inventors: Schlienger; Nathalie (Frederiksberg, DK)
Assignee: Acadia Pharmaceuticals Inc. (San Diego, CA)
Appl. No.: 329719
Filed: December 23, 2002
Primary Examiner: Shah; Mukund J.
Assistant Examiner: Habte; Kahsay
Attorney, Agent or Firm: Knobbe Martens Olson & Bear LLP
RELATED APPLICATIONS
The present application claims priority to U.S. Provisional Application Ser. No. 60/344,750, filed Dec. 28, 2001, by Schlienger, and entitled "SPIROAZACYCLIC COMPOUNDS AS MONOAMINE RECEPTOR MODULATORS," which is incorporated by reference herein in its entirety, including any drawings.
--------------------------------------------------------------------------------
Claims
--------------------------------------------------------------------------------
1. A compound of formula I, salts and stereoisomers thereof: ##STR8##
wherein...........
(snip, 16 claims total) |
